Changes in membrane adenosine triphosphatases on administration of lithium salts in vivo.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D001714:Bipolar Disorder / Q000201:enzymology; D002118:Calcium / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000201:enzymology*; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006801:Humans; D008094:Lithium / Q000494:pharmacology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013570:Synaptic Membranes / Q000187:drug effects / Q000201:enzymology
D008094:Lithium; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium; D002118:Calcium